Wall Street Zen Upgrades DaVita (NYSE:DVA) to “Buy”

DaVita (NYSE:DVA) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday.

DVA has been the topic of a number of other research reports. Barclays upped their price target on shares of DaVita from $143.00 to $158.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 3rd. UBS Group upped their target price on DaVita from $186.00 to $190.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of DaVita in a report on Monday, December 29th. TD Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 3rd. Finally, Truist Financial set a $158.00 price objective on shares of DaVita in a research report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $155.80.

DaVita Price Performance

DaVita stock opened at $150.89 on Friday. The stock’s 50 day moving average is $120.72 and its 200 day moving average is $125.15. DaVita has a one year low of $101.00 and a one year high of $157.12. The firm has a market cap of $10.08 billion, a P/E ratio of 15.23, a P/E/G ratio of 0.53 and a beta of 0.99.

DaVita (NYSE:DVA) last released its earnings results on Monday, February 2nd. The company reported $3.40 earnings per share for the quarter, beating analysts’ consensus estimates of $3.24 by $0.16. The business had revenue of $3.62 billion during the quarter, compared to the consensus estimate of $3.51 billion. DaVita had a net margin of 5.47% and a negative return on equity of 413.18%. The company’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.24 EPS. DaVita has set its FY 2026 guidance at 13.600-15.00 EPS. Equities analysts anticipate that DaVita will post 10.76 earnings per share for the current fiscal year.

Institutional Trading of DaVita

Several hedge funds have recently bought and sold shares of DVA. National Pension Service acquired a new position in DaVita during the 3rd quarter valued at about $1,305,000. Todd Asset Management LLC purchased a new stake in shares of DaVita in the third quarter worth approximately $21,842,000. Assenagon Asset Management S.A. lifted its holdings in shares of DaVita by 1,951.8% in the third quarter. Assenagon Asset Management S.A. now owns 68,408 shares of the company’s stock valued at $9,089,000 after purchasing an additional 65,074 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of DaVita by 175.1% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 18,409 shares of the company’s stock valued at $2,446,000 after buying an additional 11,718 shares during the last quarter. Finally, Rakuten Investment Management Inc. bought a new stake in DaVita during the third quarter worth $19,875,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.